盘点爱康国宾涉诉情况：曾被判赔偿当事人10万元

Core Viewpoint - The article discusses the controversies surrounding Aikang Guobin, particularly focusing on customer complaints regarding misdiagnosis and missed diagnoses during health check-ups, leading to legal disputes and public scrutiny [1][5]. Group 1: Customer Complaints and Legal Disputes - Customer Zhang's allegations against Aikang Guobin include claims of missed cancer risk warnings despite ten years of health check-ups, culminating in a cancer diagnosis in 2024 [1]. - Similar disputes have occurred, such as a case involving a customer who discovered a liver hemangioma after Aikang Guobin failed to detect it during a check-up, leading to a court ruling that found Aikang Guobin negligent [2]. - In another case, a customer was awarded 100,000 yuan after Aikang Guobin failed to detect cervical cancer during routine screenings, which the court attributed to the company's negligence [3][4]. Group 2: Company Defense and Legal Outcomes - Aikang Guobin maintains that the allegations from customers are unfounded and asserts that their testing procedures are accurate, offering to accept third-party evaluations to validate their claims [5]. - The company argues that customers should take responsibility for their health conditions if they do not disclose relevant medical history during check-ups [4]. - Some legal outcomes have not favored customers, as seen in a case where a claim was dismissed due to a lack of causal relationship between the health check and subsequent medical issues [4].